Innospec Inc. is a specialty chemical company that develops, manufactures, blends, markets, and supplies products across three reportable segments: Performance Chemicals, Fuel Specialties, and Oilfield Services. The Performance Chemicals segment provides technology-based solutions for personal care, home care, agrochemical, construction, mining, and other industrial markets. The Fuel Specialties segment produces additives for diesel, jet, marine, fuel oil, and other fuels to improve efficiency, engine performance, and emissions, including the AvGas product line for aviation gasoline. The Oilfield Services segment supplies chemical solutions for drilling, completion, production, and drag reduction in oil and gas exploration. The company serves customers in the Americas, Europe, the Middle East, Africa, and Asia-Pacific, including multinational oil companies, fuel marketers, personal care manufacturers, and exploration and production firms.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Specialty Chemicals Homepage innospec.com
Sector Basic Materials IR page investors.innospec.com
Tags
fuel additives, oilfield chemicals, personal care ingredients, home care ingredients, agrochemicals, construction chemicals, mining chemicals, drag reducing agents, aviation gasoline additives, AvGas
Press page —

Metrics

Valuation  
Market cap $ 1.963B
Market cap (USD) $ 1.963B
P/E 14.08
PEG —
P/BV 1.43
P/S 1.05
P/OCF 18.95
P/FCF 31.26
Dividend yield 0.01%
Turnover / mcap —
Returns  
ROE 9.2%
ROI 10.9%
ROIC 10.2%
Profit margin 6.6%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -4.3%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 6
Quality score -10.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 1.778B 1.845B 1.949B 1.964B 1.483B 1.193B 1.513B 1.477B 1.307B 883.4M 1.012B 960.9M 818.8M 776.4M 774.4M 683.2M 598.5M 640.5M 602.4M 532.1M 527.7M 480.5M 462.2M 451.5M 420.9M 422.4M
Net profit 116.6M 35.6M 139.1M 133M 93.1M 28.7M 112.2M 85M 61.8M 81.3M 119.5M 84.1M 77.8M 68.3M 48.9M 73.7M 6.4M 12.5M 29.5M 11.4M -123.7M 6.2M 51.8M 52.1M 5.6M 18.3M
Free cash flow 62.8M 122.2M 130.1M 39.4M 54.1M — — — — — 100.1M 92.8M 50.2M 52.5M 27.7M 49.4M 80.2M 5.3M 35.7M 28.8M 35.5M 52.8M 77.4M 88.6M 81.6M 127.4M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 76.54 110.06 123.24 102.86 90.34 90.73 103.44 61.76 70.6 68.5 54.31 42.7 46.22 34.42 28.04 37.36 13.24 7.61 22.62 47.25 — — — — — —
Price performance 12m -0.3 -0.11 0.2 0.14 -0 -0.12 0.67 -0.13 0.03 0.26 0.27 -0.08 0.34 0.23 -0.25 1.82 0.74 -0.66 -0.52 — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 154M 245M 280M 292M 221M 285M 335M 360M 342M 342M
↳ YoY growth +12.4% +58.4% +14.4% +4.4% -24.2% +28.5% +17.6% +7.5% -5.0% +0.2%
↳ 5y CAGR +9.2% +16.1% +15.5% +12.2% +10.0% +13.0% +6.5% +5.2% +3.2% +9.1%
Borrowings, current (USD) 10.3M 15.8M 21.4M 0.00 0.00 — — — — —
Borrowings, non-current (USD) 259M 203M 186M 58.6M 0.00 — — — — —
Lease liabilities (USD) — — 0.00 32.5M 40.2M 35.6M 45.3M 45.2M 44.9M 52.7M
Cash and deposits (USD) 102M 90.2M 123M 75.7M 105M 142M 147M 204M 289M 293M
Intangible assets (USD) 144M 163M 136M 114M 75.3M 57.5M 45M 57.3M 65.4M 67.7M
Right-of-use assets (USD) — — 0.00 32.4M 40.1M 35.4M 45.3M 45.1M 44.8M 52.7M
Net debt (borrowings + leases - cash) (USD) 167M 128M 84.5M 15.4M -65.1M — — — — —
Cash flow detail
Operating cash flow (USD) 105M 82.7M 105M 162M 146M 93.2M 81.7M 207M 185M 138M
Purchases of intangible assets (USD) 0.00 -4.2M 0.00 0.00 — — — — — —
Change in receivables (cash effect) (USD) -6M -83.2M -40.1M -18.2M 74.4M -70.3M -55.5M -12.6M 4.3M 21.6M
Change in inventories (cash effect) (USD) 7.7M -30.8M -42.2M 2.4M 25.5M -62M -98.5M 83M -11.8M -6.6M
Change in payables (cash effect) (USD) -3.4M 48.6M 38.4M 23.2M -45.9M 90.2M 54.2M -26.9M -4.5M -32.8M
Dividends paid (cash effect) (USD) -15.9M -18.6M -21.7M -25M -25.6M -28.8M -31.7M -35.1M -38.8M -42.4M
Share buybacks (cash effect) (USD) -8.4M -1.1M -1.4M -2.4M -2.1M -800,000 -5.9M -1.1M -700,000 -23.9M
Income taxes paid (cash effect) (USD) -23.1M -24.2M -35.4M -37.6M -23.4M -36.8M -50M -54.3M -51.7M -51M
Share-based compensation (USD) 3.3M 4.1M 4.9M 6.6M 5.8M 4.4M 6.7M 8M 8.5M 8.1M
Operating cash flow before change in receivables (USD) 111M 166M 145M 180M 71.5M 164M 137M 220M 180M 117M
Income detail
Research and development expense (USD) 25.4M 31.4M 33.4M 35.4M 30.9M 37.4M 38.7M 41.7M 47.8M 51M
↳ 5y CAGR +6.8% +9.9% +9.5% +9.8% +4.1% +8.0% +4.3% +4.5% +6.2% +10.5%
Total comprehensive income (USD) 66M 150M 47.8M 114M 45.8M 104M 34.7M 136M 92.7M 173M
Comprehensive income to owners (USD) 66M — — — — — — — — —
Reported Feb 15, 2018 Feb 15, 2018 May 8, 2019 Feb 19, 2020 Feb 17, 2021 Feb 16, 2022 Feb 22, 2023 Feb 14, 2024 Feb 19, 2025 Feb 18, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

November 3, 2026

PDF Version

All businesses contributed to revenue and operating income growth

Continued strength in Fuel Specialties; Double-digit operating income growth in Performance Chemicals and Oilfield Services

Cash flow of $17.4 million generated from operations; Net cash improved to $251.9 million

GAAP EPS $1.29 and adjusted non-GAAP EPS $1.29

Semi-annual dividend of 94 cents; Annual dividend increased by 9 percent

ENGLEWOOD, Colo., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced its financial results for the third quarter ended September 30, 2026 and declared a semi-annual dividend of 94 cents per common share for the second half of 2026, which will be paid on November 25, 2026 to shareholders of record as of November 17, 2026. This brings the annual dividend to $1.86 per share, a 9 percent increase over 2025.

Total revenues for the third quarter were $473.6 million, an increase of 7 percent from $441.9 million in the corresponding period last year. Net income attributable to Innospec for the quarter was $31.8 million or $1.29 per diluted share, compared to $12.9 million or 52 cents per diluted share recorded last year.

Adjusted EBITDA for the quarter was $51.4 million compared to $44.2 million reported in the same period a year ago. Innospec generated cash from operating activities of $17.4 million, before capital expenditures of $15.6 million in the quarter. The quarter closed with net cash of $251.9 million.

Results for this quarter include some special items, which are summarized in the table below. Excluding these items, adjusted non-GAAP EPS in the third quarter was $1.29 per diluted share, compared to $1.12 per diluted share a year ago.

Adjusted EBITDA and net income attributable to Innospec excluding special items and related per-share amounts together with net cash, are non-GAAP financial measures that are defined and reconciled with GAAP results herein and in the schedules below.

| | | Quarter ended September 30, 2026 | Quarter ended September 30, 2025 |

| | | | | | | | | | | | | |

| (in millions, except share and per share data) | | Net income attributable to Innospec | | | Diluted EPS | | | Net income attributable to Innospec | | | Diluted EPS | |

| | | | | | | | | | | | | |

| Reported GAAP amounts | $ | 31.8 | | $ | 1.29 | | $ | 12.9 | | $ | 0.52 | |

| | | | | | | | | | | | | |

| Adjustment to fair value of contingent consideration | | (1.1 | ) | | (0.04 | ) | | (17.7 | ) | | (0.71 | ) |

| Amortization of acquired intangible assets | | 0.8 | | | 0.03 | | | 1.7 | | | 0.07 | |

| Legacy costs of closed operations | | 0.7 | | | 0.03 | | | 0.8 | | | 0.03 | |

| Foreign currency exchange gains | | (0.4 | ) | | (0.02 | ) | | (2.4 | ) | | (0.10 | ) |

| Impairment of property, plant and equipment | | - | | | - | | | 18.1 | | | 0.73 | |

| Impairment of intangible assets | | - | | | - | | | 14.0 | | | 0.56 | |

| Restructuring charge | | - | | | - | | | 0.6 | | | 0.02 | |

| | | 0.0 | | | 0.0 | | | 15.1 | | | 0.60 | |

| | | | | | | | | | | | | |

| Adjusted non-GAAP amounts | $ | 31.8 | | $ | 1.29 | | $ | 28.0 | | $ | 1.12 | |

| | | | | | | | | | | | | |

Commenting on the third quarter results, Patrick S. Williams, President and Chief Executive Officer, said,

“This was another good quarter for Innospec with all businesses contributing to solid revenue and strong operating income growth.

Performance Chemicals sales growth and margin improvement drove an 84 percent operating income increase over last year. In North Carolina, we expect to commission our recent plant efficiency upgrades by year-end. These upgrades are expected to increase capacity, productivity and yields on a wide range of personal care and other products. As utilization of this new capacity improves and progress on new products continues, we expect further growth and margin improvement in the coming quarters.

Fuel Specialties had another strong quarter delivering revenue growth and steady operating income with margins that remained within our target range. As expected, the business has continued to deliver consistent results.

Oilfield Services operating income grew 40 percent and operating margins improved, driven by our recent DRA plant expansion. While sequential results were lower than expected on continued activity delays in our legacy Middle East business and elevated raw material costs, we are expecting improvement across several of these areas to drive sequential operating income growth in the fourth quarter.”

Revenues in Performance Chemicals of $180.5 million were up 6 percent from $170.8 million in the third quarter of last year. Volume reductions of 5 percent and a negative currency impact of 1 percent were offset by a positive price and product mix of 12 percent. Gross margins of 18.8 percent increased by 3.7 percentage points from the same quarter last year. Operating income of $16.9 million increased 84 percent from $9.2 million in the prior year period.

Revenues in Fuel Specialties of $180.7 million were up 5 percent from $172.0 million in the third quarter of last year. Volumes were up 3 percent and price and product mix were up 2 percent. Gross margins of 35.1 percent decreased by 0.5 percentage points over last year. Operating income of $35.6 million was up 1 percent from $35.3 million a year ago.

Revenues in Oilfield Services of $112.4 million for the quarter were up 13 percent from $99.1 million in the third quarter of last year. Gross margins of 28.2 percent decreased by 1.8 percentage points from the same quarter last year on a weaker sales mix. Operating income of $6.7 million increased 40 percent from $4.8 million in the prior year period.

Corporate costs for the quarter were $18.6 million, compared with $18.2 million a year ago. The adjusted effective tax rate for the quarter was 24.7 percent compared to 22.7 percent in the same period last year, due to the geographical mix of taxable profits.

For the quarter, cash provided by operating activities was $17.4 million compared to $39.1 million a year ago. As of September 30, 2026, Innospec had $251.9 million in cash and cash equivalents and no debt.

Mr. Williams concluded,

“Again this quarter Innospec delivered solid sales and strong operating income growth with higher margins. We remain focused on significant opportunities for continued growth and margin improvement across all our businesses and in particular Performance Chemicals and Oilfield Services.

Operating cash generation was positive in the quarter, and our net cash position remained at over $250 million. We continue to focus on driving increased operating cash flow in the coming quarters with better working capital efficiency. We have significant balance sheet flexibility for organic investment, M&A, dividend growth, and buybacks. This quarter our Board approved a further increase in our semi-annual dividend to 94 cents per share resulting in an annual dividend increase of 9 percent.”

Use of Non-GAAP Financial Measures

The information presented in this press release includes financial measures that are not calculated or presented in accordance with Generally Accepted Accounting Principles in the United States (GAAP). These non-GAAP financial measures comprise adjusted EBITDA, net income attributable to Innospec excluding special items and related per share amounts together with net cash. Adjusted EBITDA is net income attributable to Innospec per our consolidated financial statements adjusted for the exclusion of interest income, net, income taxes, depreciation and amortization, foreign currency exchange (gains)/losses, legacy costs of closed operations, adjustment to fair value of contingent consideration, restructuring charge, impairment of property, plant and equipment and impairment of intangible assets. Net income attributable to Innospec and diluted EPS, excluding special items, per our consolidated financial statements are adjusted for the exclusion of adjustment to fair value of contingent consideration, amortization of acquired intangible assets, legacy costs of closed operations, foreign currency exchange gains, impairment of property, plant and equipment, impairment of intangible assets and restructuring charge. Net cash is cash and cash equivalents less total debt. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided herein and in the schedules below.

The Company believes that such non-GAAP financial measures provide useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, these non-GAAP measures address questions the Company routinely receives from analysts and investors and the Company has determined that it is appropriate to make this data available to all investors. While the Company believes that such measures are useful in evaluating the Company’s performance, investors should not consider them to be a substitute for financial measures prepared in accordance with GAAP. In addition, these non-GAAP financial measures may differ from similarly titled non-GAAP financial measures used by other companies and do not provide a comparable view of the Company’s performance relative to other companies in similar industries. Management uses adjusted EPS (the most directly comparable GAAP financial measure for which is GAAP EPS) and net income attributable to Innospec excluding special items and adjusted EBITDA (the most directly comparable GAAP financial measure for which is GAAP net income attributable to Innospec) to allocate resources and evaluate the performance of the Company’s operations and has provided a reconciliation of adjusted EBITDA and net income attributable to Innospec excluding special items, and related per share amounts, to GAAP net income attributable to Innospec herein and in the schedules below.

About Innospec Inc.

Innospec Inc. is an international specialty chemicals company with approximately 2,450 employees in 22 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. The Performance Chemicals business creates innovative technology-based solutions for our customers in the Personal Care, Home Care, Agrochemical, Mining and Industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Oilfield Services provides specialty chemicals to all elements of the oil and gas exploration and production industry.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like “expects,” “estimates,” “anticipates,” “may,” “could,” “believes,” “feels,” “plans,” “intends,” “outlook” or similar words or expressions, for example) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future. Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements. Additional information regarding risks, uncertainties and assumptions relating to Innospec and affecting our business operations and prospects are described in Innospec’s Annual Report on Form 10-K for the year ended December 31, 2025, Innospec’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 and other reports filed with the U.S. Securities and Exchange Commission. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading "Risk Factors” in such reports. Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

October 5, 2026

PDF Version

ENGLEWOOD, Colo., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2026 earnings results on Tuesday, November 3, 2026 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, November 4, 2026, at 9:00 a.m. ET.

The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal PIN which can be used to join the conference 5-10 minutes prior to the start time.

Online Registration Link https://register-conf.media-server.com/register/BI7cb12fd38c4b4fd49b83e66c0479e55f

An audio webcast of the conference call will run simultaneously on the company’s website at www.innospec.com. The relevant link as well as the slide presentation for the conference call will be found in the Investor Relations section of the website.

A replay of the webcast can also be accessed from the company’s website and will be available for 30 days following the call.

About Innospec Inc.

Innospec Inc. is an international specialty chemicals company with approximately 2,500 employees in 22 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. The Performance Chemicals business creates innovative technology-based solutions for our customers in the Personal Care, Home Care, Agrochemical, Mining and Industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Oilfield Services provides specialty chemicals to all elements of the oil and gas exploration and production industry.

Forward-Looking Statements

This presentation contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like “expects,” “estimates,” “anticipates,” “may,” “could,” “believes,” “feels,” “plans,” “intends,” “outlook” or similar words or expressions, for example) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future. Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements. Additional information regarding risks, uncertainties and assumptions relating to Innospec and affecting our business operations and prospects are described in Innospec’s Annual Report on Form 10-K for the year ended December 31, 2025, Innospec’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 and other reports filed with the U.S. Securities and Exchange Commission. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading "Risk Factors” in such reports. Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

August 4, 2026

PDF Version

Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent

Continued strength in Fuel Specialties and further improvement in Performance Chemicals and Oilfield Services

Debt-free balance sheet with over $250 million in net cash; $6.4 million in share repurchases

GAAP EPS $1.25 and adjusted non-GAAP EPS $1.27

ENGLEWOOD, Colo., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced its financial results for the second quarter ended June 30, 2026.

Total revenues for the second quarter were $491.4 million, an increase of 12 percent from $439.7 million in the corresponding period last year. Net income attributable to Innospec for the quarter was $30.8 million or $1.25 per diluted share compared to $23.5 million or 94 cents per diluted share recorded in the second quarter last year. Adjusted EBITDA for the quarter was $50.1 million compared to $49.1 million reported in the same period a year ago.

Results for this quarter include some special items, which are summarized in the table below. Excluding these items, adjusted non-GAAP EPS in the second quarter was $1.27 per diluted share, compared to $1.26 per diluted share a year ago.

Cash from operating activities was $7.2 million before capital expenditure of $16.5 million. The quarter closed with net cash of $250.2 million. In the second quarter, the Company paid its semi-annual dividend of 92 cents per common share and repurchased 87,089 of its common shares under the share repurchase program at a cost of $22.7 million and $6.4 million respectively.

Adjusted EBITDA and net income attributable to Innospec excluding special items and related per-share amounts together with net cash, are non-GAAP financial measures that are defined and reconciled with GAAP results herein and in the schedules below.

| | | Quarter ended June 30, 2026 | Quarter ended June 30, 2025 |

| | | | | | | | | | |

| (in millions, except share and per share data) | | Net income attributable to Innospec | | Diluted EPS | | Net income attributable to Innospec | | Diluted EPS | |

| | | | | | | | | | |

| Reported GAAP amounts | $ | 30.8 | $ | 1.25 | $ | 23.5 | $ | 0.94 | |

| | | | | | | | | | |

| Foreign currency exchange (gains)/losses | | (0.9) | | (0.04) | | 3.5 | | 0.14 | |

| Amortization of acquired intangible assets | | 0.8 | | 0.03 | | 1.6 | | 0.06 | |

| Legacy costs of closed operations | | 0.7 | | 0.03 | | 2.3 | | 0.09 | |

| Adjustment to fair value of contingent consideration | | 0.1 | | - | | 0.8 | | 0.03 | |

| | | 0.7 | | 0.02 | | 8.2 | | 0.32 | |

| | | | | | | | | | |

| Adjusted non-GAAP amounts | $ | 31.5 | $ | 1.27 | $ | 31.7 | $ | 1.26 | |

Commenting on the second quarter results, Patrick S. Williams, President and Chief Executive Officer, said,

“This was a strong quarter for Innospec with all businesses contributing to double digit operating income growth.

Performance Chemicals operating leverage drove a 15 percent operating income increase over last year. In North Carolina we continue to advance our plant repairs, process improvements and upgrades to meet customer requirements. In parallel, we continue to execute on a range of other topline and margin opportunities identified in the business. We expect these combined efforts to drive further improvement in the second half of 2026.

Fuel Specialties had another strong quarter delivering revenue and operating income growth with margins that remained within our target range. As expected, the business continued to deliver consistently as our team advances on a broad set of regional and end-market opportunities in traditional fuel, renewable fuel and non-fuel applications.

Oilfield Services operating income and margins improved sequentially and on the prior year, driven by our recent DRA plant expansion and growing opportunities to deliver this industry-leading technology to our customers. In addition, we remain focused on driving growth and margin improvement in our US and Middle East completions and production business. We are confident that these combined efforts will drive further sequential improvement in the second half of 2026.”

Revenues in Performance Chemicals of $190.3 million were up 9 percent from $173.8 million in the second quarter of last year. Volume reductions of 2 percent were offset by a positive price/mix of 8 percent and a positive currency impact of 3 percent. Gross margins of 17.3 percent decreased by 0.2 percentage points from the same quarter last year. Operating income of $16.4 million increased 15 percent from $14.3 million in the corresponding prior year period.

Revenues in Fuel Specialties of $185.7 million were up 12 percent from $165.1 million in the second quarter of last year. Volumes were up 7 percent with price/mix up 3 percent and a positive currency impact of 2 percent. Gross margins of 36.6 percent decreased by 1.5 percentage points over last year. Operating income of $36.3 million increased 3 percent from $35.4 million a year ago.

Revenues in Oilfield Services of $115.4 million for the quarter were up 14 percent from $100.8 million in the second quarter of last year. Gross margins of 32.3 percent increased by 2.7 percentage points from the same quarter last year. Operating income of $8.7 million increased 40 percent from $6.2 million in the prior year period.

Corporate costs for the quarter were $21.6 million compared with $20.9 million a year ago.

The effective tax rate for the quarter was 25.0 percent compared to 26.0 percent in the same period last year, reflecting the geographical location of taxable profits.

For the quarter, cash provided by operating activities was $7.2 million compared to $10.5 million a year ago. As of June 30, 2026, Innospec had $250.2 million in cash and cash equivalents and no debt.

Mr. Williams concluded,

“This was a strong quarter for Innospec driven by improved performance in all our businesses. We remain focused on further technology development, topline growth and margin improvement opportunities, and we are optimistic about the impact that these actions will have on future results.

Operating cash generation was positive in the quarter, and our net cash position closed at over $250 million. We expect increased operating cash flow in the second half as we improve working capital efficiency. We continue to have significant balance sheet flexibility for organic investment, M&A, dividend growth, and buybacks. This quarter we continued our record of returning value to shareholders with our semi-annual dividend of 92 cents per share and $6.4 million in share repurchases.”

Use of Non-GAAP Financial Measures

The information presented in this press release includes financial measures that are not calculated or presented in accordance with Generally Accepted Accounting Principles in the United States (GAAP). These non-GAAP financial measures comprise adjusted EBITDA, net income attributable to Innospec excluding special items and related per share amounts together with net cash. Adjusted EBITDA is net income attributable to Innospec per our consolidated financial statements adjusted for the exclusion of interest income, net, income taxes, depreciation and amortization, foreign currency exchange (gains)/losses, legacy costs of closed operations and adjustment to fair value of contingent consideration. Net income attributable to Innospec and diluted EPS, excluding special items, per our consolidated financial statements are adjusted for the exclusion of foreign currency exchange (gains)/losses, amortization of acquired intangible assets, legacy costs of closed operations and adjustment to fair value of contingent consideration. Net cash is cash and cash equivalents less total debt. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided herein and in the schedules below.

The Company believes that such non-GAAP financial measures provide useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, these non-GAAP measures address questions the Company routinely receives from analysts and investors and the Company has determined that it is appropriate to make this data available to all investors. While the Company believes that such measures are useful in evaluating the Company’s performance, investors should not consider them to be a substitute for financial measures prepared in accordance with GAAP. In addition, these non-GAAP financial measures may differ from similarly titled non-GAAP financial measures used by other companies and do not provide a comparable view of the Company’s performance relative to other companies in similar industries. Management uses adjusted EPS (the most directly comparable GAAP financial measure for which is GAAP EPS) and net income attributable to Innospec excluding special items and adjusted EBITDA (the most directly comparable GAAP financial measure for which is GAAP net income attributable to Innospec) to allocate resources and evaluate the performance of the Company’s operations and has provided a reconciliation of adjusted EBITDA and net income attributable to Innospec excluding special items, and related per share amounts, to GAAP net income attributable to Innospec herein and in the schedules below.

About Innospec Inc.

Innospec Inc. is an international specialty chemicals company with approximately 2,450 employees in 22 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. The Performance Chemicals business creates innovative technology-based solutions for our customers in the Personal Care, Home Care, Agrochemical, Mining and Industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Oilfield Services provides specialty chemicals to all elements of the oil and gas exploration and production industry.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like “expects,” “estimates,” “anticipates,” “may,” “could,” “believes,” “feels,” “plans,” “intends,” “outlook” or similar words or expressions, for example) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future. Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements. Additional information regarding risks, uncertainties and assumptions relating to Innospec and affecting our business operations and prospects are described in Innospec’s Annual Report on Form 10-K for the year ended December 31, 2025, Innospec’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 and other reports filed with the U.S. Securities and Exchange Commission. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading "Risk Factors” in such reports. Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Prompts

Innospec Inc. (ticker IOSP), listed in United States.

Company History

Date Change Detail
Jan 30, 2006 Renamed OCTEL CORP → INNOSPEC INC.

ETFs Holding Innospec Inc.

ETF Weight in ETF Shares Market value As of
TCV 1.54% 39,124 $ 3.05M Nov 18, 2026
HSMV 1.07% 744 $ 58.902K Nov 16, 2026
JPSV 0.72% 2,610 $ 203.606K Nov 17, 2026
FSEV 0.61% 500 $ 40.695K Jun 30, 2026
SCDS 0.40% 466 $ 36.353K Nov 17, 2026
HWSM 0.31% 104 $ 8,464.56 Jun 30, 2026
SQLV 0.26% 914 $ 74.39K Jun 30, 2026
RUSC 0.21% 2,006 $ 163.268K Jun 30, 2026
FSML 0.20% 3,129 $ 254.669K Jun 30, 2026
FSEG 0.19% 136 $ 11.069K Jun 30, 2026
JMEE 0.19% 67,773 $ 5.287M Nov 17, 2026
IVSS 0.19% 620 $ 50.462K Jun 30, 2026
AVSC 0.12% 49,979 $ 3.91M Nov 16, 2026
DFSV 0.10% 360,957 $ 28.555M Nov 12, 2026
FESM 0.10% 71,510 $ 5.82M Jun 30, 2026
SMDX 0.10% 1,597 $ 124.933K Nov 17, 2026
DFAT 0.09% 362,748 $ 28.697M Nov 12, 2026
RESM 0.08% 36 $ 2,930.04 Jun 30, 2026
DFAS 0.04% 184,881 $ 14.626M Nov 12, 2026
SFGV 0.02% 2,279 $ 180K Nov 18, 2026
DXUV 0.02% 15,279 $ 1.209M Nov 12, 2026
MSSM 0.01% 894 $ 83.911K Aug 31, 2026
FEAC 0.01% 36 $ 2,930.04 Jun 30, 2026
DFUV 0.01% 19,933 $ 1.577M Nov 12, 2026
DFAC 0.01% 101,709 $ 8.046M Nov 12, 2026
DFSU 0.01% 2,603 $ 205.923K Nov 12, 2026
DCOR 0.01% 34,589 $ 2.736M Nov 12, 2026
EBI 0.00% 321 $ 30.129K Aug 31, 2026
DFAU 0.00% 6,368 $ 503.772K Nov 12, 2026
DFUS 0.00% 7,796 $ 616.742K Nov 12, 2026
AVUS 0.00% 8,119 $ 635.149K Nov 16, 2026